Donor Egg In Vitro Fertilization Services Market Forecast 2025–2032: Trends & Insights

According to a newly published market research report by 24LifeSciences, global donor egg IVF services market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 11.3% during the forecast period 2025–2032.

Download a Free Sample Report (PDF): https://www.24lifesciences.com..../download-sample/154

Global Solitary Fibrous Tumor Treatment Market Analysis & Future Opportunities

According to a newly published market research report by 24LifeSciences, global solitary fibrous tumor treatment market was valued at USD 120 million in 2025 and is projected to reach USD 210 million by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2026–2034.

Download a Free Sample Report (PDF): https://www.24lifesciences.com..../download-sample/152

Intervertebral Fusion Device Market Size, Share & Revenue Outlook 2032

According to a newly published market research report by 24LifeSciences, global intervertebral fusion device market was valued at USD 2740 million in 2024 and is projected to reach USD 3601 million by 2031, growing at a compound annual growth rate (CAGR) of 4.0% during the forecast period 20252031.

Download a Free Sample Report (PDF): https://www.24lifesciences.com..../download-sample/518

Lubricating Eye Drops for Dry Eyes Market 4.9% CAGR: Top Companies in 2025

According to a newly published market research report by 24LifeSciences, the global lubricating eye drops for dry eyes market was valued at USD 7,087 million in 2024 and is projected to reach USD 9,811 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period 2025-2031.

Download a Free Sample Report (PDF): https://www.24lifesciences.com..../download-sample/440

Recombinant Hepatitis E vaccine Market Size, Share & Revenue Outlook 2032

According to a newly published market research report by 24LifeSciences, global recombinant Hepatitis E vaccine market was valued at USD 165.7 million in 2024 and is projected to reach USD 289.4 million by 2032, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 20252032.

Download a Free Sample Report (PDF): https://www.24lifesciences.com..../download-sample/140